46 companies

Grifols

Market Cap: €6.8b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

GRF

€11.20

7D

1.9%

1Y

19.1%

PharmaEssentia

Market Cap: NT$183.1b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

6446

NT$495.00

7D

1.2%

1Y

-10.8%

China Resources Pharmaceutical Group

Market Cap: HK$28.3b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

3320

HK$4.51

7D

-1.3%

1Y

-16.9%

Hypera

Market Cap: R$14.8b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$23.33

7D

-0.1%

1Y

30.2%

Lotus Pharmaceutical

Market Cap: NT$74.2b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

1795

NT$282.00

7D

1.3%

1Y

6.6%

Harmony Biosciences Holdings

Market Cap: US$2.2b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

HRMY

US$37.38

7D

-2.0%

1Y

7.5%

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥14.6b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

603707

CN¥9.03

7D

-2.0%

1Y

-26.3%

Bora Pharmaceuticals

Market Cap: NT$61.0b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

6472

NT$492.00

7D

-1.1%

1Y

-21.0%

Organon

Market Cap: US$1.9b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

OGN

US$7.24

7D

0.8%

1Y

-53.1%

Pacific Shuanglin Bio-pharmacy

Market Cap: CN¥13.0b

Engages in research, development, production, and sales of blood products in China and internationally.

000403

CN¥13.69

7D

-3.2%

1Y

-17.9%

Hugel

Market Cap: ₩2.5t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

A145020

₩235,000.00

7D

3.5%

1Y

-12.0%

Neuren Pharmaceuticals

Market Cap: AU$2.4b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$18.91

7D

-4.0%

1Y

55.0%

Alvotech

Market Cap: US$1.6b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

ALVO

US$5.00

7D

-4.9%

1Y

-62.3%

Collegium Pharmaceutical

Market Cap: US$1.4b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

COLL

US$45.53

7D

-8.6%

1Y

54.3%

KPC PharmaceuticalsInc

Market Cap: CN¥9.5b

A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally.

600422

CN¥12.56

7D

-0.8%

1Y

-19.6%

Shanghai Haohai Biological Technology

Market Cap: HK$10.2b

Shanghai Haohai Biological Technology Co., Ltd.

6826

HK$24.30

7D

-4.8%

1Y

-5.1%

L&C BIOLTD

Market Cap: ₩1.5t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

A290650

₩62,400.00

7D

-0.3%

1Y

130.3%

Genomma Lab Internacional. de

Market Cap: Mex$17.5b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

LAB B

Mex$17.93

7D

-0.8%

1Y

-30.7%

Strides Pharma Science

Market Cap: ₹83.0b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

STAR

₹900.75

7D

-1.1%

1Y

29.0%

Tong Ren Tang Technologies

Market Cap: HK$5.7b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

1666

HK$4.44

7D

-0.4%

1Y

-12.4%

Emergent BioSolutions

Market Cap: US$657.0m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

EBS

US$12.51

7D

0.6%

1Y

21.2%

Newron Pharmaceuticals

Market Cap: CHF 476.1m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

NWRN

CHF 23.85

7D

0.8%

1Y

170.7%

Medy-Tox

Market Cap: ₩859.2b

Operates as a biopharmaceutical company in South Korea.

A086900

₩122,400.00

7D

4.1%

1Y

-1.9%

DongKook Pharmaceutical

Market Cap: ₩764.1b

Produces and sells pharmaceutical products in South Korea and internationally.

A086450

₩17,080.00

7D

-2.0%

1Y

4.8%

Dong-A Socio Holdings

Market Cap: ₩693.1b

Engages in the pharmaceutical business in South Korea.

A000640

₩107,700.00

7D

-2.3%

1Y

6.0%

Zevra Therapeutics

Market Cap: US$469.5m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

ZVRA

US$8.34

7D

-6.0%

1Y

-2.9%

Blau Farmacêutica

Market Cap: R$2.5b

A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

BLAU3

R$13.91

7D

6.9%

1Y

7.8%

SIGA Technologies

Market Cap: US$449.0m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

SIGA

US$6.27

7D

0%

1Y

-0.9%

Clinuvel Pharmaceuticals

Market Cap: AU$638.1m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

CUV

AU$12.71

7D

-0.5%

1Y

6.0%

Beximco Pharmaceuticals

Market Cap: ৳45.5b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

BXPHARMA

৳101.90

7D

-6.0%

1Y

30.3%

Abeona Therapeutics

Market Cap: US$287.8m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$5.31

7D

-2.6%

1Y

-11.8%

JBM (Healthcare)

Market Cap: HK$2.2b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

2161

HK$2.65

7D

-2.6%

1Y

39.5%

Essex Bio-Technology

Market Cap: HK$2.2b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

1061

HK$3.81

7D

-2.1%

1Y

33.2%

Egyptian International Pharmaceutical Industries

Market Cap: ج.م13.1b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

PHAR

ج.م77.50

7D

1.7%

1Y

67.8%

Laboratorio Reig Jofre

Market Cap: €218.1m

A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food.

RJF

€2.68

7D

3.9%

1Y

4.3%

Coherus Oncology

Market Cap: US$165.6m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

New

CHRS

US$1.37

7D

3.0%

1Y

-17.5%

Page 1 of 2